Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 6/20 | 0.34 |
| ▸ | HTR2C | P28335 | 1/20 | 0.34 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.32 |
| ▸ | RAD52 | P43351 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL608138 | 1.00 | TSHR (0.41) | TSHRALDH1A1CYP3A4NAAAEPHX1 | |
| SCHEMBL475356 | 0.97 | ALDH1A1 (0.37) | TSHRALDH1A1CYP3A4NAAAEPHX1 | |
| SCHEMBL608729 | 0.89 | ALDH1A1 (0.36) | TSHRALDH1A1CYP3A4NAAATDP1 | |
| SCHEMBL30515234 | 0.89 | NAAA (0.55) | TSHRALDH1A1NAAAEPHX1FAAH | |
| SCHEMBL26614417 | 0.86 | NAAA (0.52) | TSHRALDH1A1CYP3A4NAAAEPHX1 | |
| SCHEMBL6932112 | 0.86 | EPHX1 (0.39) | TSHRALDH1A1CYP3A4NAAAEPHX1 | |
| SCHEMBL608988 | 0.82 | TSHR (0.39) | TSHRALDH1A1CYP3A4NAAAEPHX1 | |
| SCHEMBL31399605 | 0.80 | ALDH1A1 (0.56) | TSHRALDH1A1CYP3A4NAAAEPHX1 | |
| SCHEMBL31399453 | 0.80 | ALDH1A1 (0.56) | TSHRALDH1A1CYP3A4NAAAEPHX1 | |
| SCHEMBL31399442 | 0.80 | ALDH1A1 (0.56) | TSHRALDH1A1CYP3A4NAAAEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2218708-B1 | METHOD FOR PRODUCING CARBONATE COMPOUND | ASAHI GLASS CO LTD (JP) | 2014-06-25 | — | — | EP | disclosed |
| US-20130230770-A1 | NON-AQUEOUS SECONDARY BATTERY | HITACHI MAXELL, LTD. (JP) | 2013-09-05 | — | — | US | disclosed |
| US-20120045698-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY USING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-02-23 | — | — | US | disclosed |
| US-20120040252-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY USING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-02-16 | — | — | US | disclosed |
| EP-2278652-A2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery using the same | Mitsubishi Chemical Corporation (JP) | 2011-01-26 | — | — | EP | disclosed |
| US-7803487-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery using the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2010-09-28 | — | — | US | disclosed |
| US-20100240912-A1 | METHOD FOR PRODUCING CARBONATE COMPOUND | ASAHI GLASS COMPANY, LIMITED | 2010-09-23 | — | — | US | disclosed |
| US-20100216036-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY USING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2010-08-26 | — | — | US | disclosed |
| EP-2218708-A1 | METHOD FOR PRODUCING CARBONATE COMPOUND | Asahi Glass Co., Ltd. (JP) | 2010-08-18 | — | — | EP | disclosed |
| US-20080102375-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY USING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2008-05-01 | — | — | US | disclosed |
| EP-1898485-A1 | NONAQUEOUS ELECTROLYTE, AND RECHARGEABLE BATTERY WITH NONAQUEOUS ELECTROLYTE | Mitsubishi Chemical Corporation (JP) | 2008-03-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100240912-A1 | METHOD FOR PRODUCING CARBONATE COMPOUND | CA6, FRG1, CA3 | TSHR 3410/4885ALDH1A1 4678/4885CYP3A4 533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.